Genprex GNPX
NASDAQ GNPX
$3.95 -0.04 (-1.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Genprex (GNPX) EBT (2016 - 2025)

Genprex (GNPX) posted quarterly EBT of -$693150.0 for Q1 2025, up 88.46% year-over-year from -$367797.3 in Q1 2024, and up 83.59% quarter-over-quarter from -$4.2 million in Q4 2024.

Genprex (GNPX) EBT (2016 - 2025) Analysis & Trends

Genprex's EBT history runs 10 years deep, the most recent figure standing at -$693150.0 for Q1 2025.

  • In Q1 2025, EBT rose 88.46% year-over-year to -$693150.0; the TTM figure through Mar 2025 stood at -$15.8 million (up 43.03% YoY), while the FY2025 annual figure was -$46.1 million, up 5.33% from the prior year.
  • EBT for Q1 2025 stood at -$693150.0, up from -$4.2 million in the prior quarter.
  • The five-year high for EBT was -$693150.0 in Q1 2025, with the low at -$9.3 million in Q1 2023.
  • The 5-year median for EBT is -$5.9 million (2023), against an average of -$5.7 million.
  • The sharpest annual moves came in 2022 and 2025: EBT slumped 79.42% in 2022, then jumped 88.46% in 2025.
  • Genprex's EBT stood at -$6.8 million in 2021, then gained by 3.03% to -$6.5 million in 2022, then rose by 9.12% to -$5.9 million in 2023, then gained by 28.98% to -$4.2 million in 2024, then jumped by 83.59% to -$693150.0 in 2025.
  • Business Quant data shows GNPX's EBT at -$693150.0 in Q1 2025, -$4.2 million in Q4 2024, and -$4.3 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 1.39 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 1.53 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 541.00 Mn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -767.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 312.46 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 177.81 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -11.37 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 81.49 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -264.70 Mn
10 Genprex 1.89 Mn -13.27 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 -693,150.00
Dec 31, 2024 -4.23 Mn
Sep 30, 2024 -4.35 Mn
Jun 30, 2024 -6.53 Mn
Mar 31, 2024 -6.01 Mn
Dec 31, 2023 -5.95 Mn
Sep 30, 2023 -7.76 Mn
Jun 30, 2023 -8.01 Mn
Mar 31, 2023 -9.26 Mn
Dec 31, 2022 -6.55 Mn
Sep 30, 2022 -6.17 Mn
Jun 30, 2022 -5.79 Mn
Mar 31, 2022 -5.31 Mn
Dec 31, 2021 -6.75 Mn
Sep 30, 2021 -3.44 Mn
Jun 30, 2021 -3.99 Mn
Mar 31, 2021 -5.31 Mn
Dec 31, 2020 -5.23 Mn
Sep 30, 2020 -2.77 Mn
Jun 30, 2020 -4.37 Mn